Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):837-854. doi: 10.1016/j.cvsm.2019.04.008. Epub 2019 Jun 6.
PMID:31176457
Emerging signaling mediators in the anorexia-cachexia syndrome of cancer.
Talbert EE, Guttridge DC.
Trends Cancer. 2022 May;8(5):397-403. doi: 10.1016/j.trecan.2022.01.004. Epub 2022 Feb 18.
PMID:35190301
Randomized Double-Blind Placebo-Controlled Study of Olanzapine for Chemotherapy-Related Anorexia in Patients With Locally Advanced or Metastatic Gastric, Hepatopancreaticobiliary, and Lung Cancer.
Sandhya L, Devi Sreenivasan N, Goenka L, Dubashi B, Kayal S, Solaiappan M, Govindarajalou R, Kt H, Ganesan P.
J Clin Oncol. 2023 May 10;41(14):2617-2627. doi: 10.1200/JCO.22.01997. Epub 2023 Mar 28.
PMID:36977285
Medical Complications in Anorexia and Bulimia Nervosa.
Gravina G, Milano W, Nebbiai G, Piccione C, Capasso A.
Endocr Metab Immune Disord Drug Targets. 2018;18(5):477-488. doi: 10.2174/1871530318666180531094508.
SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).
Soria Rivas A, Escobar Álvarez Y, Blasco Cordellat A, Majem Tarruella M, Molina Mata K, Motilla de la Cámara M, Del Mar Muñoz Sánchez M, Zafra Poves M, Beato Zambrano C, Cabezón Gutierrez L.